Literature DB >> 1552918

Anti-endotoxin monoclonal antibodies--a second look.

R P Wenzel.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1552918     DOI： 10.1056/NEJM199204233261710

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  Direct identification of bacteria from positive blood cultures by amplification and sequencing of the 16S rRNA gene: evaluation of BACTEC 9240 instrument true-positive and false-positive results.

Authors:  Q Qian; Y W Tang; C P Kolbert; C A Torgerson; J G Hughes; E A Vetter; W S Harmsen; S O Montgomery; F R Cockerill; D H Persing
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 2.  Drug utilisation review and pharmacoeconomics: interaction after parallel development?

Authors:  S Garattini; G Tognoni
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

Review 3.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

4.  Novel monoclonal antiendotoxin antibody therapy: efficacy at any price?

Authors:  W K Fant
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

Review 5.  Sepsis and septic shock. II. Treatment.

Authors:  J Mayer; R Hajek; J Vorlicek; M Tomiska
Journal:  Support Care Cancer       Date:  1995-03       Impact factor: 3.603

Review 6.  Gram-negative sepsis: a dilemma of modern medicine.

Authors:  R C Bone
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

Review 7.  Infectious diseases.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1994-02       Impact factor: 2.401

8.  The HA-1A saga: the scientific and ethical dilemma of innovative and costly therapies.

Authors:  C Brun-Buisson
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

9.  Pharmacodynamic evaluation of the neutralization of endotoxin by PMX622 in mice.

Authors:  Philip Lake; Jeffrey DeLeo; Franklin Cerasoli; Lennart Logdberg; Marla Weetall; Dean Handley
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

Review 10.  Infections in cancer patients: some controversial issues.

Authors:  S C Schimpff; D A Scott; J C Wade
Journal:  Support Care Cancer       Date:  1994-03       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.